Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|October 17, 2024
Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysisAnnika Strönisch, Daniel Rau, Silvan Wittenberg, et al.
Cancers|January 21, 2022
The Role of Stereotactic Radiosurgery in the Management of Foramen Magnum Meningiomas-A Multicenter Analysis and Review of the LiteratureFelix Ehret, Markus Kufeld, Christoph Fürweger, et al.
Cancers|February 12, 2021
Robotic Radiosurgery for Persistent Postoperative Acromegaly in Patients with Cavernous Sinus-Invading Pituitary Adenomas-A Multicenter ExperienceFelix Ehret, Markus Kufeld, Christoph Fürweger, et al.
JAMA Network Open|April 29, 2022
Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical ResectionDavid Wasilewski, Josefine Radke, Ran Xu, et al.
International Journal of Cancer|February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancerSebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Cancer Management and Research|April 3, 2023
Sarcoma Patients Admitted to the Intensive Care Unit (ICU): Predictive Relevance of Common Sepsis and Performance ParametersJana K Striefler, Phung T Binder, Franziska Brandes, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 22, 2016
Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94)Pirus Ghadjar, Christoph Pöttgen, Daniela Joos, et al.
BJU International|October 28, 2020
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinomaStephanie G C Kroeze, Corinna Fritz, Jana Schaule, et al.
The Oncologist|August 10, 2024
Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomasSebastian F Winter, Melissa M Gardner, Philipp Karschnia, et al.
Pageof 13